We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+4.27%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+433.28%
AUM
$203B
AUM Growth
+$19.6B
Cap. Flow
+$8.95B
Cap. Flow %
4.4%
Top 10 Hldgs %
24.49%
Holding
9,765
New
1,572
Increased
4,160
Reduced
2,819
Closed
1,012

Top Buys

Rank Stock Value
1
C icon
Citigroup
C
+$702M
2
AMAT icon
Applied Materials
AMAT
+$507M
3
KDP icon
Keurig Dr Pepper
KDP
+$387M
4
KEY icon
KeyCorp
KEY
+$383M
5
V icon
Visa
V
+$349M

Sector Composition

Rank Sector Weight
1 Financials 6.16%
2 Technology 4.5%
3 Industrials 4.26%
4 Consumer Discretionary 4.07%
5 Healthcare 3.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACHN
8276
PUT
DELISTED
Achillion Pharmaceuticals
ACHN
$51K ﹤0.01%
+17,900
New +$61K
AXSM icon
8277
Axsome Therapeutics
AXSM
$12.1B
$50K ﹤0.01%
+15,581
New +$48.3K
PLUR icon
8278
CALL
Pluri
PLUR
$16.8M
$50K ﹤0.01%
510
+144
+39% +$15.1K
JRJC
8279
DELISTED
China Finance Online Co., Ltd.
JRJC
$50K ﹤0.01%
2,629
-650
-20% -$13.5K
PFX icon
8280
PUT
PhenixFIN
PFX
$83.1M
$48K ﹤0.01%
685
-60
-8% -$4.57K
ISEE
8281
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$48K ﹤0.01%
+17,483
New +$48.2K
EPE
8282
CALL
DELISTED
EP Energy Corporation
EPE
$48K ﹤0.01%
16,000
+5,600
+54% +$13.3K
SENS icon
8283
PUT
Senseonics Holdings Inc
SENS
$265M
$47K ﹤0.01%
+575
New +$41.2K
CLD
8284
PUT
DELISTED
Cloud Peak Energy Inc
CLD
$47K ﹤0.01%
13,400
-700
-5% -$2.33K
BDSI
8285
CALL
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$47K ﹤0.01%
+15,800
New +$37.5K
AST
8286
DELISTED
Asterias Biotherapeutics Inc. Series A
AST
$47K ﹤0.01%
+34,543
New +$52.9K
MBOT icon
8287
Microbot Medical
MBOT
$117M
$46K ﹤0.01%
4,126
-5,620
-58% -$68.4K
SSKN
8288
DELISTED
Strata Skin Sciences
SSKN
$46K ﹤0.01%
2,252
+64
+3% +$1.04K
IMBI
8289
DELISTED
iMedia Brands, Inc. Class A Common Stock
IMBI
$46K ﹤0.01%
+3,779
New +$41.6K
EVK
8290
DELISTED
Ever-Glory International Group, Inc.
EVK
$46K ﹤0.01%
+13,389
New +$51.6K
CODA icon
8291
Coda Octopus Group
CODA
$115M
$45K ﹤0.01%
11,352
+200
+2% +$776
HDSN
8292
PUT
Hudson Technologies
HDSN
$244M
$45K ﹤0.01%
+22,200
New +$72K
HMY icon
8293
Harmony Gold Mining
HMY
$10.1B
$45K ﹤0.01%
28,794
-52,354
-65% -$97.9K
IBRX icon
8294
ImmunityBio
IBRX
$7.8B
$45K ﹤0.01%
14,663
-9,491
-39% -$35.1K
IMNN icon
8295
CALL
Imunon
IMNN
$6.72M
$45K ﹤0.01%
+77
New +$38.2K
OMED
8296
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
$45K ﹤0.01%
19,555
-35,023
-64% -$102K
AST
8297
PUT
DELISTED
Asterias Biotherapeutics Inc. Series A
AST
$45K ﹤0.01%
+33,000
New +$50.6K
AWRE icon
8298
CALL
Aware
AWRE
$24.9M
$44K ﹤0.01%
+10,800
New +$43.5K
CPRX
8299
DELISTED
Catalyst Pharmaceutical
CPRX
$44K ﹤0.01%
14,051
-87,402
-86% -$265K
GGB icon
8300
CALL
Gerdau
GGB
$9.74B
$44K ﹤0.01%
15,498
-5,040
-25% -$17.6K

Similar funds

Citadel Advisors's Q2 2018 Portfolio in Review

As of Q2 2018, Citadel Advisors held 9,765 positions worth $203B, up 11% from $184B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Citadel Advisors deployed $8.95B of net new capital in Q2 2018, opening 1,572 new positions and adding to 4,160 existing holdings. Its largest new stake was Equitable Holdings: 16,008,962 shares worth $330M.

By sector, the portfolio is most concentrated in Financials at 6.2% of assets, up from 4.9% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $948M trimmed.

  • Citadel Advisors's largest Q2 2018 buy was Equitable Holdings: 16,008,962 shares worth $330M.
  • Citadel Advisors added most to Citigroup in Q2 2018, an estimated $702M increase.
  • Citadel Advisors's biggest Q2 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $948M.
  • Citadel Advisors fully exited Time Warner Inc in Q2 2018, selling an estimated $268M.
  • Citadel Advisors's ten largest holdings make up 24% of its $203B portfolio in Q2 2018.
  • Citadel Advisors opened 1,572 new positions and closed 1,012 in Q2 2018.
  • Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $203B.

Based on Citadel Advisors's 13F filing for Q2 2018, filed 10 Aug 2018.